"Vaccines, Subunit" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines consisting of one or more antigens that stimulate a strong immune response. They are purified from microorganisms or produced by recombinant DNA techniques, or they can be chemically synthesized peptides.
| Descriptor ID |
D022223
|
| MeSH Number(s) |
D20.215.894.860
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vaccines, Subunit".
Below are MeSH descriptors whose meaning is more specific than "Vaccines, Subunit".
This graph shows the total number of publications written about "Vaccines, Subunit" by people in this website by year, and whether "Vaccines, Subunit" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 4 | 5 |
| 2009 | 3 | 3 | 6 |
| 2010 | 5 | 5 | 10 |
| 2011 | 1 | 2 | 3 |
| 2012 | 0 | 4 | 4 |
| 2013 | 3 | 0 | 3 |
| 2015 | 3 | 3 | 6 |
| 2016 | 1 | 2 | 3 |
| 2017 | 2 | 3 | 5 |
| 2018 | 3 | 3 | 6 |
| 2019 | 1 | 1 | 2 |
| 2020 | 3 | 4 | 7 |
| 2021 | 1 | 3 | 4 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccines, Subunit" by people in Profiles.
-
The EEHV1A gH/gL complex elicits humoral and cell-mediated immune responses in mice. Vaccine. 2024 Oct 03; 42(23):126227.
-
Identification of a Self-Assembling Small-Molecule Cancer Vaccine Adjuvant with an Improved Toxicity Profile. J Med Chem. 2023 09 28; 66(18):13266-13279.
-
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ. Cancer Prev Res (Phila). 2023 06 01; 16(6):333-341.
-
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2. Emerg Microbes Infect. 2022 Dec; 11(1):2724-2734.
-
Potential association factors for developing effective peptide-based cancer vaccines. Front Immunol. 2022; 13:931612.
-
An in silico approach to study the role of epitope order in the multi-epitope-based peptide (MEBP) vaccine design. Sci Rep. 2022 07 22; 12(1):12584.
-
EEHV1A glycoprotein B subunit vaccine elicits humoral and cell-mediated immune responses in mice. Vaccine. 2022 08 19; 40(35):5131-5140.
-
Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches. PeerJ. 2022; 10:e13380.
-
Immune epitopes identification and designing of a multi-epitope vaccine against bovine leukemia virus: a molecular dynamics and immune simulation approaches. Cancer Immunol Immunother. 2022 Oct; 71(10):2535-2548.
-
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine. 2022 02 23; 40(9):1253-1260.